These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1849762

  • 1. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD, Logue FC, Gallacher SJ, O'Reilly DS, Beastall GH, Ralston SH, Boyle IT.
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [Abstract] [Full Text] [Related]

  • 2. Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.
    Gallacher SJ, Fraser WD, Logue FC, Dryburgh FJ, Cowan RA, Boyle IT, Ralston SH.
    Calcif Tissue Int; 1992 Dec; 51(6):419-23. PubMed ID: 1333351
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.
    Gurney H, Grill V, Martin TJ.
    Lancet; 1993 Jun 26; 341(8861):1611-3. PubMed ID: 8099988
    [Abstract] [Full Text] [Related]

  • 4. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
    Coukell AJ, Markham A.
    Drugs Aging; 1998 Feb 26; 12(2):149-68. PubMed ID: 9509293
    [Abstract] [Full Text] [Related]

  • 5. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
    Walls J, Ratcliffe WA, Howell A, Bundred NJ.
    Br J Cancer; 1994 Jul 26; 70(1):169-72. PubMed ID: 8018531
    [Abstract] [Full Text] [Related]

  • 6. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ.
    Cancer; 1994 Apr 15; 73(8):2223-30. PubMed ID: 8156530
    [Abstract] [Full Text] [Related]

  • 7. Tubular excretion of phosphate in Paget's disease of bone. Effect of pamidronate.
    Constantin A, Laroche M, Moulinier L, Bon E, Ramonjisoa M, Cantagrel A, Mazieres B.
    Rev Rhum Engl Ed; 1995 Apr 15; 62(7-8):493-500. PubMed ID: 8574612
    [Abstract] [Full Text] [Related]

  • 8. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V, Murray RM, Ho PW, Santamaria JD, Pitt P, Potts C, Jerums G, Martin TJ.
    J Clin Endocrinol Metab; 1992 Jun 15; 74(6):1468-70. PubMed ID: 1592895
    [Abstract] [Full Text] [Related]

  • 9. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
    Stewart GO, Gutteridge DH, Price RI, Ward L, Retallack RW, Prince RL, Stuckey BG, Kent GN, Bhagat CI, Dhaliwal SS.
    Bone; 1999 Feb 15; 24(2):139-44. PubMed ID: 9951784
    [Abstract] [Full Text] [Related]

  • 10. The effect of alendronate on renal tubular reabsorption of phosphate.
    Vasikaran SD, O'Doherty DP, McCloskey EV, Gertz B, Kahn S, Kanis JA.
    Bone Miner; 1994 Oct 15; 27(1):51-6. PubMed ID: 7849546
    [Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
    Dodwell DJ, Abbas SK, Morton AR, Howell A.
    Eur J Cancer; 1991 Oct 15; 27(12):1629-33. PubMed ID: 1782072
    [Abstract] [Full Text] [Related]

  • 12. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
    Papapoulos SE, Harinck HI, Bijvoet OL, Gleed JH, Fraher LJ, O'Riordan JL.
    Bone Miner; 1986 Feb 15; 1(1):69-78. PubMed ID: 3508718
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
    Walls J, Ratcliffe WA, Howell A, Bundred NJ.
    Clin Endocrinol (Oxf); 1994 Oct 15; 41(4):407-13. PubMed ID: 7955450
    [Abstract] [Full Text] [Related]

  • 14. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA, Zysset E, Jenzer A, Thiébaud D, Ammann P, Rizzoli R, Jaquet-Müller F, Bonjour JP, Gertz B, Burckhardt P.
    J Bone Miner Res; 1994 Apr 15; 9(4):521-6. PubMed ID: 8030440
    [Abstract] [Full Text] [Related]

  • 15. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP, Patron P, Fouqueray B, Prigent A, Paillard M.
    Miner Electrolyte Metab; 1988 Apr 15; 14(4):221-8. PubMed ID: 2850460
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
    van Breukelen FJ, Bijvoet OL, Frijlink WB, Sleeboom HP, Mulder H, van Oosterom AT.
    Calcif Tissue Int; 1982 Jul 15; 34(4):321-7. PubMed ID: 6814719
    [Abstract] [Full Text] [Related]

  • 17. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
    Oiso Y, Tomita A, Hasegawa H, Ariyoshi Y, Niinomi M, Yamamoto M, Takano T, Sakiyama N.
    Endocr J; 1994 Dec 15; 41(6):655-61. PubMed ID: 7704089
    [Abstract] [Full Text] [Related]

  • 18. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
    Malberti F, Farina M, Imbasciati E.
    Nephrol Dial Transplant; 1999 Oct 15; 14(10):2398-406. PubMed ID: 10528664
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
    Abramson EC, Kukreja SC, Lad TE, Shemerdiak WP, York PA.
    Horm Metab Res; 1984 Apr 15; 16(4):204-7. PubMed ID: 6327481
    [Abstract] [Full Text] [Related]

  • 20. The effect of age on the renal response to PTH infusion.
    Naafs MA, Fischer HR, Koorevaar G, Hackeng WH, Schopman W, Silberbusch J.
    Calcif Tissue Int; 1987 Nov 15; 41(5):262-6. PubMed ID: 2825933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.